chrisvoncsefalvay/vaers-outcomes huggingface dataset:
This spontaneous report received from a nurse, refers to a 14 years old female patient. The patient had no pertinent medical history or drug allergies. On 28-JUL-2014, the patient received the first dose of GARDASIL (0.5ml, once), intramuscularly. The patient received the second dose of GARDASIL on 06-JUL-2015 (reported as 'did not receive the second dose until 06-JUL-2015'). The patient did not experience any adverse events to the first two doses of the series. On 14-NOV-2015 the patient was vaccinated with the third dose of GARDASIL, (lot # J007850), Expiry: 07-APR-1016) in the right arm. Concomitant therapy included CLARITIN. On the same day, the patient experienced 5 cm swelling in the deltoid muscle of the right arm around the injection site. On 17-NOV-2015, the patient went to the physician's office with the event. The area was found to be flushed and was very tender to palpation. There were no hives or flushing on any other area of the body. On an unknown date in November 2015 the patient also experienced low grade fever and headache. No lab tests were performed. The physician advised the patient to apply ice packs in the affected area and to take ADVIL or TYLENOL as needed for pain and if the symptoms did not improved. The action taken with the vaccine was not applicable. The outcome of all events were unknown. No product quality issue was involved. The causality of the events were not assessed by the reporter. Additional information has been requested.
Persistent pain in arm, pain when lifting arm, I believe it to be SIRVA. Also I had a miscarriage at 10 weeks pregnant (18 days after receiving second dose) although that may not be related to the vaccination.
About two to three days after my booster, I started feeling lethargic and it felt like I had taken a Xanax, everything was in slow motion and the colors were weird. It persisted for a week to 8 days, then went away. I told my general practitioner and she told me she had two cases that had that experience. I don't want to give her name.
I am not sure if I marked the right vaccines but on 8-16-12 he had PENTA (DTP AND PV on his shot record),  HIB, HEP B, PCV  Event on 9-16-2012 he had a fever of 102.8 I took him to the ER the night before but they made us sit forever like 4 hours bc of other emergencies so we decided to go to quickcare the next day They dx him with otitis media.
Patient experienced nausea, sore throat, muscle weakness, it was an effort to move, sore throat, severe headache lightheaded, "just didn`t feel right and very tired starting that afternoon
left arm is uncontrollably twitching/Twitching now in the other arm, both calves and thighs; This spontaneous case was reported by a consumer and describes the occurrence of MUSCLE TWITCHING (left arm is uncontrollably twitching/Twitching now in the other arm, both calves and thighs) in a 63-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concurrent medical conditions included Autoimmune disorder and Lung disorder.    In March 2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced MUSCLE TWITCHING (left arm is uncontrollably twitching/Twitching now in the other arm, both calves and thighs). At the time of the report, MUSCLE TWITCHING (left arm is uncontrollably twitching/Twitching now in the other arm, both calves and thighs) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No relevant concomitant medications were reported.   Patient stated that, after two and half weeks of receiving vaccine, she started noticing that her left arm muscle was uncontrollably twitching which was extended to another arm, both the calves and both thighs. The consumer reported that it was not painful, but  noticeable. No treatment information was provided.
not received 2nd dose yet; This non-serious case was reported by a pharmacist via call center representative and described the occurrence of incomplete course of vaccination in a female patient who received Herpes zoster (Shingrix) for prophylaxis.   Previously administered products included Shingrix (1st dose received on 14 February 2021).   On an unknown date, the patient did not receive the 2nd dose of Shingrix. On an unknown date, an unknown time after receiving Shingrix, the patient experienced incomplete course of vaccination (Verbatim: not received 2nd dose yet). The outcome of the incomplete course of vaccination was unknown.   Additional Information: GSK Receipt Date: 01-NOV-2023 The pharmacist called to inquired did the patient need to repeat the series as the patient received the Shingrix first dose back 14 February 2021 and never came back for the second dose. The reporter asked how to proceed. Till the time of reporting, the patient did not receive 2nd dose of Shingrix, which led to incomplete course of vaccination. The reporter did not consent to follow up.
Patient received The Pfizer vaccine on 4/26/2021 that had an expiration date of 4/25/2021 at 1:25pm, which was 120 hours after taken from the freezer.
Pt recv vax on 11/8/98; on 11/22/98 pt exp muscular weakness to hands, then general weakness; progressed to paralysis; dx= Guillain Barre syndrome; pt hosp/ ICU; tx=plasmapheresis, intubated for ventilation
eye was swollen that night,  left side of head , left side of neck, back and shoulder were numb and slurring of speech. bad headache, covid arm.
This case was reported by a nurse and described the occurrence of nausea in a 23-year-old female patient who received RABAVERT. Concomitant products included RABAVERT and RABAVERT. On an unknown date, the patient received the 3rd dose of RABAVERT. On an unknown date, less than a day after receiving RABAVERT, the patient experienced nausea and vomiting. On an unknown date, the outcome of the nausea and vomiting were unknown. It was unknown if the reporter considered the nausea and vomiting to be related to RABAVERT. Additional details were provided as follows: It was unknown whether the patient received RABAVERT for pre or post exposure prophylaxis. The age at vaccination was not reported. On an unknown date, the patient received 1st and 2nd dose of RABAVERT. After receiving RABAVERT, patient experienced nausea and vomiting within 24 hours of injection. This was 1 of 3 cases reported by the same reporter for same patient.
Complained of headaches constantly, and stomach pain and nausea over the 2 1/2 months after last HPV shot Dec 30 2016. Then in March 2017 the pain was so bad she couldn't eat, stayed out of school due to pain, lost alot of weight. (20 lbs in 3weeks) currently 96 lbs. She stopped having periods after last shot. She was hospitalized 3x in 3 months due to pain and weight loss and a low heart rate. Abdominal pain was so severe no pain meds helped. Finally decided diagnosis of chronic abdominal pain. She is always cold. Has a slow digestive motility. Currently 6mths after last shots still has severe abdominal pain and headaches. Has to take drink supplements for food replacements to get more calories in her. At the age of 16, told it will be a life long problem and will have to learn how to manage pain.
The pt had five mild seizures in the five days following the vax. He could not hold up his head/back. He looked "out of it", was unresponsive and then cried. Each episode lasted 30-60 seconds. The seizures started with strong breathing.
After the vaccine I had normal side effects: sore arm, low grade fever, chills, etc. About 36-48 hours later I began to feel tenderness in my labia. Shortly after I noticed vulvar aphthous ulcers develop, which lasted 3-4 days. I had about a dozen small ulcers on my labia minora, which made urinating and general movement painful. I saw my pcp on Feb 17th or 18th but they had mostly resolved. She ruled out any STIs or other issues. I had this reaction to my first dose as well.
Arm was hot and swollen and looks like she had a pink sunburn; This spontaneous case was reported by a consumer and describes the occurrence of INFLAMMATION (Arm was hot and swollen and looks like she had a pink sunburn) in a 32-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 023M20A) for COVID-19 vaccination.     No Medical History information was reported.    On 17-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 17-Feb-2021, the patient experienced INFLAMMATION (Arm was hot and swollen and looks like she had a pink sunburn). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency and ACETYLSALICYLIC ACID (ASPIRIN (E.C.)) at an unspecified dose and frequency. At the time of the report, INFLAMMATION (Arm was hot and swollen and looks like she had a pink sunburn) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitants- Generic allergy medication
Pt recvd booster MMR II vax & exp an anaphylactic reaction w/ swelling of the eyelids,wheezing & tachycardia.
Fever, sever headaches, body aches, diarrhea, swollen face  for 2 days , body flushing, redness and swelling at injection site, 24 hour sleep after initial symptoms began   Question if I should take second dose. Heart doctor suggested I might want anEpi pen on hand if I do!
Knot and swelling on right anterior thigh (treated with BACTROBAN, KEFLEX, and SEPTRA through hospital ER).
First period after 2nd dose was different from my usual periods.  I was very nauseous and even vomited.  I was extremely fatigued and had to take a 2 hour nap. I never nap. I was very hungry more cravings than my normal periods.  Cramping was more painful and lasted longer
Sore arm started ~5hr s/p injection and persisted for 2 days. Mild-moderate headache started ~5-6hr s/p injection and lasted for 2 days. 1 day s/p injection had eye itching that lasted 3 days.
Pt Pt became pale & diaphoretic, losing conciousness for 2-3 seconds.  Transported to Observation Area.  BP 118/72 P60 R16. Says has a history of fainting with IV's.    Pt stabilized & released & he notified wife that he was coming home.
Within a few hours a swath of blisters appeared on my right ankle, and over the next 48 one appeared on my temple. The ankle blisters contained clear fluid, the one on temple contained blood.  Also experience severe flu-like muscle aches and pains between 24 and 48 hours.
COVID-19; COVID-19; This is a spontaneous report received from a non-contactable reporter(s) (Other HCP). The reporter is the patient.  A 25-year-old male patient received BNT162b2 (BNT162B2), on 30Dec2020 as dose 1, single (Batch/Lot number: unknown), in left arm, on 20Jan2021 as dose 2, single (Batch/Lot number: unknown), in left arm and on 30Sep2021 as dose 3 (booster), single (Batch/Lot number: unknown), in left arm for covid-19 immunisation. The patient's relevant medical history included: "Asthma" (unspecified if ongoing); "Known allergies: dairy" (unspecified if ongoing); "Known allergies: Shellfish" (unspecified if ongoing). There were no concomitant medications. The following information was reported: VACCINATION FAILURE (medically significant), COVID-19 (medically significant), outcome "unknown" and all described as "COVID-19". Rebound covid beginning 5 days post finishing paxlovid treatment. Rebound lasted for 5 days before testing negative again. The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: Positive, notes: COVID 19 Treatment; Negative, notes: Rebound lasted for 5 days before testing negative again; Negative, notes: before testing negative again. Therapeutic measures were taken as a result of vaccination failure, covid-19. The patient received COVID-19 treatment with Paxlovid from 29Jun2022 to 03Jul2022. No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.; Sender's Comments: Based on available information a contributory role of BNT162B2 to the reported events Covid-19 and vaccination failure cannot be totally excluded as efficacy of a drug varies from individual to individual depending upon the immune status. As with any vaccine, vaccination with BNT162B2 may not protect all vaccine recipients, so the expectedness of covid-19 and vaccination failure  is : expected. The case will be reassessed further upon receipt of additional information.
Slumped over after receiving vaccine.  Hx vasovagal with previous vaccines.  Pt evaluated by MD & EMTs, DC home in stable condition.
The Tdap shot was administered 10/20/2020 by a pharmacy tech who injected into a site that was lower than typical on my right arm; rather than near the top where most of the muscle is, the shot site was approximately 6 inches below the top of the shoulder and caused significant pain at the time of the injection, and for a couple of days afterwards - not my usual experience taking vaccines.  (I also received shot one of the Shingrix vaccine on the same day on the left arm, but due to the nature of my report, do not think it is associated with the issue I am reporting.) A few months later, around July of 2021, my wife noticed a bulge in the back of my right arm, almost precisely where the Tdap shot was given.  As we were leaving for an extended two month vacation and I had no specific other symptoms, I planned to review it at my annual physical in November 2021.  By this time the bulge was quite large and no longer explainable merely as a difference in muscle mass.  Upon ultrasound and MRI, this was identified as a probable lipoma, but due to the location and my age thought to be a possible liposarcoma (cancerous), which required a special surgeon at the facility - Dr. - to remove on March 4, 2022.  It was approximately 10-12 cm in size.  Fortunately, it was found to be non-cancerous.
Swelling and redness at injection site on left arm, headache, muscle aches for 2 days after vaccine. On June 22 patient noticed petechia on legs and bleeding gums. On June 23 the petechia had spread all over his body and we went to Medical Center for evaluation. Blood work showed platelet count of 2000 and he was referred to the ER at another Medical Center. MC immediately transferred him to Hospital  because he may have needed a platelet transfusion. Blood work done at hospital showed that his platelet count had dropped to 0. The hematologist diagnosed him with Immune Thrombocytopetic Purpura. He was given oral prednisone. On June 24 his platelet count was 5000. He was prescribed prednisone and discharged from the hospital.
This spontaneous report as received from a pharmacist refers to an unspecified number of patients of unknown age and gender. The patients' medical history and current conditions were not provided. On an unknown dates, the patients were vaccinated with doses of improperly stored PNEUMOVAX 23 (dose and route were not reported) lot # L033707, expiration date 18-MAY-2017. It was reported that the vaccine was exposed to 29 Fahrenheit degrees for 96 hours. No adverse experience has been reported. This is one of several reports received from the same reporter. Additional information has been requested.
PATIENT DEVELOPED HIGH FEVER (102F) AND WAS UNABLE TO MOVE RIGHT ARM. FEVER PERSISTED AFTER TYLENOL.
Approx 1-2 hrs after immunizations, infant had episode of unresponsiveness, apnea X 20-30 sec. Dad performed CPR. Admit to hosp. partial rule out sepsis w/u neg. No further sx, discharged 2 days later.
I am breastfeeding and the day after my booster my 3 month old stopped using her right arm. She has had MRIs which were negative. She has not recently been sick, nor had trauma. There is no explanation for the lack of use
Treatment of COVID-19; Treatment of COVID-19; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 32-year-old male patient received BNT162b2 (BNT162B2), as dose 2, single (Batch/Lot number: unknown) for covid-19 immunisation; coviD-19 vaccine (COVID-19 VACCINE), as dose 1, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history included: "Allergies/ Asthma" (unspecified if ongoing). There were no concomitant medications. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant), outcome "unknown" and all described as "Treatment of COVID-19". Therapeutic measures were taken as a result of drug ineffective, covid-19.  Additional information: Patient had no other vaccine in two weeks. Report about COVID treatment: Yes  The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.
patient came to pharmacy saturday 12/31/22 betwen 11am-1130am. he complained that he was sick and ill and did not go to work for a week and perceived that the reason for his illness was receiving the Boostrix and Twinrix on 12/23/2022.  He brought previous records that showed he had already received boostrix in 2022 and the records were signed by rph. Per 2022-records, patient received 3 doses of twinrix (appropriate schedule) and 2 doses of Boostrix (only 1 inject every 10 years recommended).  Thus patient believes that receiving an additional duplicate Boostrix vaccine caused him to be sick and ill and not be able to go to work for 1 week.  I printed "patient education" about Boostrix information from system and informed patient that any ADR/SE would be limited to site injection, headache, and body aches.  Nonetheless, he received boostrix twice in 2022.  I informed patient I would submit an incident report to the company as well as a VAERS incident as well obtaining records show that rph administered Boostrix on 5/20/2022 and then admistered Boostrix on 12/23/2022.  This is a duplication.   Regarding Twinrix, per records, he received dose#1 5/20/2022 by rph dose #2 7/25/2022 by rph, and dose #3 on 12/23/2022 by rph.
pt recvd vax;pt c/o sweatin; weakness;shaking during 10 min;BP range 140/100-130/90 over next 40 min;no chest tightness; no syncope or hives;pt told to rest under observation for 50 min; sent home;MD recommended DPH;however was never taken;
Patient states a couple of hours after receiving the PNEUMOVAX 23 vaccine, her left upper arm became painful, swollen and warm to the touch from the injection site down to her elbow.
Laid down for bed, heart began beating very fast. Sat up, felt uncomfortable & off - I did not recognize my own bedroom. Hands turned bright red & face was pale. Felt short of breath, very uncomfortable & anxious. First episode lasted ~20 mins. After first episode, laid back down in bed & felt heart beating quickly again. Hopped out of bed & walked around house trying to calm down. Second episode shorter than the first, only ~10 mins. Took previously prescribed beta blocker - metopralol 20mg at end of second episode. For 1 hour afterwards, body was shaking & could not get warm.  The entire event lasted about 90 mins until I felt normal again.
Arm swelling, redness, and itching. One week later left hand started to swell.
12 hours after administration, patient had freezing chills, prickly skin, aches lasting approximately 4 hours.  12 hours after the Shingles shot at 2:30am, I felt freezing cold - my skin was not icy - it felt prickly - my hands too, but also they ached.  I couldn't get warm even with blankets, long johns and warm night gown.  It's 4 AM and the intense cold has let up.  I'm drinking hot decaf tea.  I still feel prickly on my back arms, legs - but less intense.  Earlier today, I had stabbing pains on and off in my left breast.  4:15 the coldness is gone - skin feels prickly yet decreased during the day to normal.
I woke early Thursday morning with a stomach virus. On January 28th, 2023, I woke up feeling like there were hot pokers in my knees, hips, shoulders, and elbow. I used a heating pad and laid on the couch all day. I ended up taking half of a VICODIN tablet and that helped with the symptoms. Sunday morning, I woke up with the feeling of glass in my throat. I drank a lot of water and ice to stop it from hurting and completed an at home antigen COVID-19 test and it was positive. I had a tele visit the next day and was prescribed PAXLOVID which I began taking the same day. By Saturday I was back to 100 percent, feeling great and ready to return work. I woke up on February 5th with a headache. I sneezed and my nose ran the entire day. My right ear felt like it was a hot poker in it. I went in to see the doctor on Monday the 6th and she prescribed an AUGMENTIN for rhinitis and sinusitis. Tuesday, I woke up with pink eye. I called the doctor's office and the nurse said to continue taking the AUGMENTIN. My eye still feels heavy but there is no more pain or discharge in my left eye.
Patient states he started feeling tired and ill around 8:00PM on 9/8/2014. Went to bed and felt he had a fever, chills, sweats and nausea. States he vomited around 9:00PM on 9/8/2014 but then was able to sleep through the night. Reported feeling tired and weak on 9/9/2014. No other symptoms reported.
After receiving the vaccines the pt became fussy and could only be consoled if held. The duration of this reaction was four hours. The pt was treated with Tylenol.
Information has been received from a healthcare worker referring to a patient of unknown and gender. The patient's medical history was not reported. On 27-APR-2015 the patient was received improperly stored (Oka/Merck) VARIVAX (lot # K007979, dose and route unknown). Concomitant medication was not reported. No adverse effects were reported. No product quality issue (PQC) was involved. This is one of several reports received from the same source. Additional information is not expected since the reporter don't wish us to contact.
second dose 2 weeks later than the first dose; This case was reported by a nurse via call center representative and described the occurrence of drug dose administration interval too short in a 62-year-old male patient who received Herpes zoster (Shingrix) (batch number C7EX2, expiry date 26th January 2022) for prophylaxis.   Concomitant products included RECOMBINANT VARICELLA ZOSTER VIRUS SURFACE GLYCOPROTEIN E (SHINGRIX).   On 27th August 2020, the patient received the 2nd dose of Shingrix. On 27th August 2020, unknown after receiving Shingrix, the patient experienced drug dose administration interval too short. On an unknown date, the outcome of the drug dose administration interval too short was unknown.  Additional details were provided as follows: The patient received 1st dose on 14th August 2021, batch number: 73E59, expiry date:19th November 2021. The patient received the second dose of Shingrix 2 weeks later than the first dose, instead of 2 months, which led to shortening of vaccination schedule. The reporter consented to follow up.
No side affects until 7 days after shot. Developed large red swollen and itchy lump at injection site. Took antihistamines for the itching. Went away after 5 days. On day 14, broke out in hives. Do not know if hives are related, but did/ate nothing out of the ordinary.  Hives went away after a few hours.
Patient was accidentally given a third dose of an mRNA COVID-19 Vaccine. Patient first received a dose of the COVID mRNA vaccine on 01/05/2021 at a different facility and never received a second dose of COVID mRNA from that facility. Pt then received a dose of COVID mRNA from a Community Health on 04/07/2021 without informing us that he had already received one dose of COVID mRNA. Pt received a second dose of COVID mRNA from a Community Health on 05/11/2021 before we found out that he had received a dose of COVID mRNA in 01/2021. Pt showed no side effects of symptoms when monitored post-vaccine administration. Pt was informed that receiving 3 doses of mRNA COVID-19 vaccines is not advised and to report any adverse reaction or symptoms to our facility should he experience any.
Headache, chills, fever. Started around 1am and at 7am I took one dose of ibuprofen. I woke up around 11am and the symptoms were gone, but later in the afternoon I've experienced some mild chills and aches that have not required pain medication.